pentobarbital will lessen the level or impact of triazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital will reduce the level or influence of docetaxel by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Not known.
pentobarbital will lower the extent or outcome of nelfinavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will decrease the level or effect of indinavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will lower the level or effect of rolapitant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Prolonged-expression coadministration of sturdy CYP3A4 inducers with rolapitant may perhaps substantially minimize rolapitant efficacy.
pentobarbital will lower the level or result of dexamethasone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will decrease the level or result of atazanavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unfamiliar.
pentobarbital will decrease the level or outcome of tamoxifen by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will reduce the level or impact of nimodipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unknown.
Watch Closely (1)pentobarbital will decrease the extent or effect of osilodrostat by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will reduce the extent or outcome of darifenacin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
pentobarbital decreases effects of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Carefully. Coadministration of CYP3A4 inducers could decrease sufentanil concentrations and efficacy, maybe precipitating withdrawal syndrome in patients check here which have produced Actual physical dependence to sufentanil. Discontinuation of concomitantly utilized CYP3A4 inducers may raise sufentanil plasma concentration.
pentobarbital will lower the level or impact of etonogestrel by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital will minimize the extent or impact of rabeprazole by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unfamiliar.